China’s loss is India’s gain as Western drug makers pivot – despite quality, oversight concerns
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
Pharmaceutical companies are seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trials and early-stage manufacturing, industry insiders said.